CAS No. |
67392-87-4 |
中文名称 |
(4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-二甲基-3',4,4a,4b,4',5,6,6a,7a,8,8a,8b,8c,8d,9,9a-十六氢-5'H-螺环[环丙并[4,5]环戊并[1,2-a]环丙并[l]菲-7,2'-呋喃]-2,5'(3H)-二酮 |
英文名称 |
(4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-dimethyl-3',4,4a,4b,4',5,6,6a,7a,8,8a,8b,8c,8d,9,9a-hexadecahydro-5'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-7,2'-furan]-2,5'(3H)-dione |
别名 |
17-Hydroxy-7β-(hydroxyMethyl)-15β,16β-Methylene-17α-pregn-3,5(6)-diene-21-carboxylic Acid, -Lactone;7β-(HydroxyMethyl)-15β,16β-Methylene-17α-pregn-3,5(6)-diene-21,17-carbolactone;Drospirenone(Dihydrospirorenone);Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione;Drospirenone (USP32);Drospirenone, >=98%;Drosporenone;6b,7b:15b,16b-Dimethylen-3-oxo-17a-pregn-4-ene-21 |
标准英文名 |
(4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-dimethyl-3',4,4a,4b,4',5,6,6a,7a,8,8a,8b,8c,8d,9,9a-hexadecahydro-5'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-7,2'-furan]-2,5'(3H)-dione |
分子式 |
C24H30O3 |
分子量 |
366.22
|
精确分子量 |
366.22
|
SMILES |
C[C@@]12[C@@]3(OC(CC3)=O)[C@]4([H])[C@](C4)([H])[C@@]1([H])[C@@]5([H])[C@]([C@@]6(C([C@@]7([H])[C@]5([H])C7)=CC(CC6)=O)C)([H])CC2 |
标准SMILES |
C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@]12CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C |
用途 |
Drospirenone is used clinically in combination with ethinyl estradiol as a combined oral contraceptive (e.g., marketed as Yasmin); it exhibits potent progestogenic activity with additional anti-mineralocorticoid effects, helping to prevent fluid retention and associated weight gain; it also demonstrates anti-androgenic properties, which contribute to clinical benefits such as improvement of acne, enhancement of skin clarity, and regulation of body weight. |
InChIKey |
METQSPRSQINEEU-HXCATZOESA-N |